First patient in Canada receives mRNA-based bladder cancer treatment in clinical trial at the MUHC
The investigational therapy combines mRNA technology with immunotherapy...
New study finds that COVID-19 boosters help avoid breakthrough infections in immunocompromised people
Researchers focused on those with rheumatoid arthritis, lupus...
D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer
Three members of The Institute are among recipients of D2R funding to support their groundbreaking...
Researchers honoured with King Charles III's Coronation Medal for outstanding achievements
In recognition of their contributions to the understanding of neurological and respiratory disease, four members...
Inaugural Research Canada Innovates event at The Institute a resounding success
Sold-out event united health researchers and innovators to shape the future of healthcare
Experts from the McGill International TB Centre and The Institute publish a prestigious Lancet seminar on TB
Commissioned work underscores the role of tuberculosis (TB) as a leading...
Final winners announced in inaugural Networks competition
Three interdisciplinary teams awarded funding to launch innovative research networks at The Institute
Epinephrine could reduce hospitalizations in pediatric intensive care after a severe allergic reaction
Research confirms the use of epinephrine before arrival at the...
New funding for cystic fibrosis research
Larry Lands, a senior scientist at The Institute, will lead a new project focusing on rare genetic mutations
Addressing health disparities through genomics
Researcher from The Institute co-leads $8.3 million genomics sequencing project to advance for Black communities